Wegovy and Ozempic are two top products from Novo Nordisk. (Archive photo). Photo: Hollie Adams/Reuters
Novo sues counterfeit product sellers in US
Novo Nordisk announced 14 new lawsuits against pharmacies selling “unsafe and unapproved drugs claiming to contain semaglutide,” a drug developed for type 2 diabetes. Novo Nordisk has initiated 132 lawsuits across 40 US states, leading to 44 permanent injunctions to stop unsafe marketing of...
Get full access to Danish News in English
Gain exclusive access to daily news updates in English pertaining to Denmark with a Ritzau News subscription.
Already a subscriber?